Ufp Technologies (UFPT) Capital Expenditures Growth (1y) (2011 - 2025)
Ufp Technologies (UFPT) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -47.73% |
| 10 | Ufp Technologies | 1.90 Bn | 1.88 Bn | 44.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -340.19% |
| Jun 30, 2025 | 3.10% |
| Mar 31, 2025 | 62.64% |
| Sep 30, 2024 | -146.32% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -20.51% |
| Dec 31, 2023 | -360.93% |
| Sep 30, 2023 | 20.27% |
| Jun 30, 2023 | -55.06% |
| Mar 31, 2023 | -6.64% |
| Dec 31, 2022 | 165.12% |
| Sep 30, 2022 | 132.56% |
| Jun 30, 2022 | 236.50% |
| Mar 31, 2022 | 61.08% |
| Dec 31, 2021 | -14.72% |
| Sep 30, 2021 | 9.82% |
| Jun 30, 2021 | 62.07% |
| Mar 31, 2021 | 42.06% |
| Dec 31, 2020 | -6.16% |
| Sep 30, 2020 | -42.00% |